Literature DB >> 2166937

[Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].

R Guinet1, H Marlier.   

Abstract

The minimal inhibitory concentrations of 200 yeast strains (48 reference strains and 152 recently isolated from pathological products) were evaluated with a new standardized micromethod using a liquid medium comparatively for ketoconazole, itraconazole and fluconazole. The ready-to-use microtitration plates contained the antifungal agents in concentrations ranging from 100 to 0.10 mg/l. The cumulative MIC curves clearly showed the superiority of ketoconazole, fluconazole being the less active product. These results were confirmed after categorization in sensitive (S: MIC less than 0.78 mg/l), intermediate (I: 0.78 less than MIC less than 6.25) or resistant (R: MIC greater than 6.25). These results are discussed particularly for fluconazole showing the largest half-life and for which higher plasmatic levels could be achieved. Important variations were observed depending on the species and as example for Candida tropicalis the sensitivities were ketoconazole 100%, itraconazole 55% and fluconazole 0%. The less sensitive species to the 3 azoles were Saccharomyces cerevisiae and Torulopsis glabrata. This new micromethod being very easy to use and allowing the determination of fungicidal activities should be introduced in routine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166937

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  3 in total

1.  Evaluation of five commercial antifungal susceptibility testing systems.

Authors:  A Druetta; A Freydiere; R Guinet; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

2.  Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts.

Authors:  F C Odds
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

Review 3.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.